Glenmark begins phase 3 clinical trials of favipiravir – india news
[ad_1] Glenmark Pharmaceuticals Limited has started the process of conducting phase 3 clinical trials of Favipiravir among Coronavirus disease (Covid-19)
Read more[ad_1] Glenmark Pharmaceuticals Limited has started the process of conducting phase 3 clinical trials of Favipiravir among Coronavirus disease (Covid-19)
Read more